Model Number FX802T |
Device Problems
Mechanical Problem (1384); Infusion or Flow Problem (2964)
|
Patient Problem
Hydrocephalus (3272)
|
Event Date 09/27/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a m.Blue (#fx802t) was implanted during a procedure performed.According to the complainant, the valve is not able to be reprogrammed externally.The membrane of the valve seems to be stuck in the pressed position.The hump of the valve cannot be felt, nor can it be heard or felt to click.The valve does not change its resistance when it is tried to be reprogrammed.Based on x-rays and programming tools, and the fact that the patient has no adverse effects, the clinic is confident that the valve is implanted correctly.The patient undergoes a revision procedure.The complained device will be returned to the manufacturer for evaluation.
|
|
Manufacturer Narrative
|
Manufacturing site evaluation: investigation on-going.Should relevant additional information / investigation results become available, a supplemental medwatch report will be submitted.
|
|
Event Description
|
The sample was returned to the manufacturer for evaluation.
|
|
Manufacturer Narrative
|
Investigation: visual inspection during the investigation, scratches on the outer housing of the valve, but no significant deformation or damage was determined.Permeability test: a permeability test has indicated that the valve has a blockage.Computer control test because the valve is not permeable, a computer control test is not applicable.Adjustment test the m.Blue was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function is operational.The braking force cannot be measured due to the non-adjustability of the valve.Internal inspection : after dismantling of the valve, deposits were found in the m.Blue.Result : based on our investigation results, we can determine a blockage and a non- adjustability at the valve.The determined deposits can be named as the cause for the functional deviations.Ortganic deposits in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
|
Search Alerts/Recalls
|